Federal contractor · ROCKVILLE, MD

DNA HIVE LLC

DNA HIVE LLC received $4.4M in federal contract obligations in FY2026, on 1 awards (+41% vs FY2025). Since FY2025: $7.5M. Its largest customer was Food and Drug Administration ($4.4M).

Obligations · FY2026
$4.4M
New awards
1
Sole-source
0.0%
Single offer
100%
UEI
ZULRXE8XYEM3
Other than small businessWoman-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 3.1MFY2025
  2. 4.4MFY2026

Top buying agencies

Obligations in FY2026.

  1. Food and Drug Administration$4.4M100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$4.4M100%

Where the work was performed

  1. Montgomery County, MD$4.4M100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $4.4M
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.8% · $4.4M
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. BAA# FY25C3AP3 - (H20) A NEXT GENERATION MEDICAL COUNTERMEASURES SCIENTIFIC PLATFORM FOR REGULATORY EVALUATION AND PREPAREDNESS$7.5M
    Food and Drug Administration· Montgomery County, MD· Research & development· Sep 23, 2025 – Sep 24, 2026· 75F40125C00095

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

DNA HIVE LLC received $0 in federal assistance in FY2026, on 0 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
0
Since FY2024
$8.7M

Assistance by fiscal year

  1. 8.7MFY2024
  2. 0FY2025

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2024–FY2025.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. THE MEDICAL DEVICE INNOVATION CONSORTIUM$6.7M
    ARLINGTON, VA · 80% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  2. ROCHESTER INSTITUTE OF TECHNOLOGY$4.2M−99% in FY2026
    ROCHESTER, NY · 60% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  3. TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC$4.1M
    WEBSTER, TX · 55% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.